𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nomogram use for the prediction of indolent prostate cancer : Impact on screen-detected populations

✍ Scribed by Stijn Roemeling; Monique J. Roobol; Michael W. Kattan; Theo H. van der Kwast; Ewout W. Steyerberg; Fritz H. Schröder


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
69 KB
Volume
110
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Screening for prostate cancer has resulted in an increased incidence‐to‐mortality ratio. Not all cancers deserve immediate treatment. It has therefore become more important to be able to identify those cases of screen‐detected prostate cancer most likely to show indolent behavior.

METHODS

The Kattan‐nomogram for the prediction of indolent prostate cancer was validated and recalibrated for use in a screening setting. The recalibrated nomogram was used to calculate the number of men who were predicted to have indolent cancer in a screen‐detected cohort from the European Randomized study of Screening for Prostate Cancer (ERSPC), section Rotterdam.

RESULTS

Of 1629 cancers detected in 2 subsequent screening rounds 825 were suitable for nomogram use. The remainder were very unlikely to have indolent cancer. A total of 485 men (485 of 825 = 59%) were predicted to have indolent cancer, which is 30% (485 of 1629) of all screen‐detected cases. Cancers found at repeated screening after 4 years had a higher probability of indolent cancer than cases from the prevalence screening (44% vs 23%; P < .001).

CONCLUSIONS

The current nomogram can identify substantial groups of screen‐detected cancers that are likely indolent and can therefore be considered for active surveillance. Cancer 2007. © 2007 American Cancer Society.


📜 SIMILAR VOLUMES


Impact of recent screening on predicting
✍ Andrew J. Vickers; Angel M. Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Beck 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

## Abstract ## BACKGROUND: Risk models to predict prostate cancer on biopsy, whether they include only prostate‐specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening hi

PSA doubling time predicts the outcome a
✍ Khatami Ali; Aus Gunnar; Damber Jan-Erik; Lilja Hans; Lodding Pär; Hugosson Jona 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 2 views

## Abstract This study reports the outcome of active surveillance in men with PSA screening‐detected prostate cancer (PC), and PSA doubling time (PSADT) was evaluated as a predictor of selecting patients to active treatment or surveillance. On December 31, 1994, 10,000 men were randomized to bienni

Negative influence of changing biopsy pr
✍ Michael J. Schwartz; David H. Hwang; Andrew J. Hung; Jullet Han; Justin W. McCla 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract ## BACKGROUND. A correlation between prostate specific antigen (PSA) level and positive prostate biopsy rate was established in an era when biopsy practice patterns were different from what they are today. We evaluated if changes in biopsy practice patterns have affected the ability of

Wash-in rate on the basis of dynamic con
✍ Jeong Kon Kim; Seong Sook Hong; Young Jun Choi; Seong Ho Park; Hanjong Ahn; Chou 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

## Abstract ## Purpose To evaluate the usefulness of the wash‐in rate based on dynamic contrast‐enhanced (DCE) MRI for the detection and localization of prostate cancer. ## Materials and Methods In 53 patients, the wash‐in rate was measured in the cancer area and in three normal areas (the perip